B3U538 AF NFT

Beta-lactamase OXA-133

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeida2jiuvwbwpu5g67vc23g7p4c2m4s5pdzfss4hbaqkkiwq7i3y7m/metadata.json
IPFS of structure file: 
bafybeiffw33miqfht6mjp4jp3d6433afj6gmj4knevigfmk64hme5x73o4/AF-B3U538-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xF8cD1d8d93E9783063700De244A6e3cf6A195579
First NFT owner address (bech32): 
genesis1lrx3mrvna9urqcmsph3yffhrea4pj4tedrk7yh
Current NFT ID #44813 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
44813
Accession (UniProt):
B3U538
Name::
Beta-lactamase OXA-133
Experimental Method:
Predicted structure
Sequence source:
ACINETOBACTER RADIORESISTENS

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B3U538 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B3U538|BL133_ACIRA Beta-lactamase OXA-133 OS=Acinetobacter radioresistens OX=40216 GN=blaOXA-133 PE=2 SV=1 MNKYFTCYVVASLFFSGCTVQHNLINETQSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTTWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVERIDFGNAEIGQQVDNFWLIGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEENNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII